Lynx1 Capital Management Lp Top Holdings and 13F Report (2026) About Lynx1 Capital Management LpInvestment ActivityLynx1 Capital Management Lp has $507.56 million in total holdings as of June 30, 2026.Lynx1 Capital Management Lp owns shares of 23 different stocks, but just 3 companies or ETFs make up 80% of its holdings.Approximately 6.81% of the portfolio was purchased this quarter.About 46.44% of the portfolio was sold this quarter.This quarter, Lynx1 Capital Management Lp has purchased 23 new stocks and bought additional shares in 4 stocks.Lynx1 Capital Management Lp sold shares of 6 stocks and completely divested from 6 stocks this quarter.Largest Holdings Cullinan Therapeutics $163,225,335Stoke Therapeutics $132,136,579Agios Pharmaceuticals $126,505,652C4 Therapeutics $34,215,647KORRO BIO INC $20,274,741 Largest New Holdings this Quarter 729139105 - Pliant Therapeutics $2,049,800 Holding344174107 - Foghorn Therapeutics $300,549 Holding05338F306 - AVALO THERAPEUTICS INC $186,648 Holding67080N101 - Nuvation Bio $91,045 Holding29842P105 - EUPRAXIA PHARMACEUTICALS INC $66,100 Holding Largest Purchases this Quarter Agios Pharmaceuticals 797,369 shares (about $29.59M)Pliant Therapeutics 1,798,070 shares (about $2.05M)C4 Therapeutics 327,789 shares (about $1.53M)TRAWS PHARMA INC 544,392 shares (about $459.09K)Foghorn Therapeutics 61,588 shares (about $300.55K) Largest Sales this Quarter Denali Therapeutics 1,868,645 shares (about $48.06M)Stoke Therapeutics 725,269 shares (about $23.73M)Xencor 518,204 shares (about $8.34M)PRECISION BIOSCIENCES INC 34,647 shares (about $272.33K)Entrada Therapeutics 33,083 shares (about $243.49K) Sector Allocation Over TimeMap of 500 Largest Holdings ofLynx1 Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCGEMCullinan Therapeutics$163,225,3350.0%8,963,50032.2%HealthcareSTOKStoke Therapeutics$132,136,579$23,730,802 â–¼-15.2%4,038,40426.0%HealthcareAGIOAgios Pharmaceuticals$126,505,652$29,590,364 â–²30.5%3,408,93724.9%HealthcareCCCCC4 Therapeutics$34,215,647$1,530,775 â–²4.7%7,326,6916.7%HealthcareKORRO BIO INC$20,274,7410.0%1,538,2964.0%COMTCRXTScan Therapeutics$7,859,5670.0%8,019,1481.5%HealthcarePRECISION BIOSCIENCES INC$7,470,663$272,325 â–¼-3.5%950,4661.5%COM NEWNEUPHORIA THERAPEUTICS INC$3,825,1830.0%875,3280.8%COMPASSAGE BIO INC$3,287,942$244,268 â–²8.0%673,7590.6%COM NEWCG ONCOLOGY INC$2,230,331$14,210 â–¼-0.6%31,3910.4%COMPLRXPliant Therapeutics$2,049,800$2,049,800 â–²New Holding1,798,0700.4%HealthcareTRDAEntrada Therapeutics$1,314,540$243,491 â–¼-15.6%178,6060.3%HealthcareVYNEVYNE Therapeutics$1,059,7950.0%1,628,7000.2%HealthcareTRAWS PHARMA INC$471,801$459,086 â–²3,610.5%559,4700.1%COM NEWFHTXFoghorn Therapeutics$300,549$300,549 â–²New Holding61,5880.1%HealthcareDNLIDenali Therapeutics$299,844$48,061,588 â–¼-99.4%11,6580.1%HealthcareXNCRXencor$292,923$8,343,073 â–¼-96.6%18,1940.1%HealthcareHOWLWerewolf Therapeutics$236,7370.0%657,7860.0%HealthcareAVALO THERAPEUTICS INC$186,648$186,648 â–²New Holding10,1000.0%COM NEWBOLT BIOTHERAPEUTICS INC$118,5800.0%30,8000.0%COM NEWNUVBNuvation Bio$91,045$91,045 â–²New Holding16,0290.0%HealthcareEUPRAXIA PHARMACEUTICALS INC$66,100$66,100 â–²New Holding10,0000.0%COMINHIBIKASE THERAPEUTICS INC$40,600$40,600 â–²New Holding20,0000.0%COM NEWGHRSGH Research$0$151,331,829 â–¼-100.0%00.0%HealthcareIMTXImmatics$0$2,135,014 â–¼-100.0%00.0%HealthcareDSGNDesign Therapeutics$0$1,271,650 â–¼-100.0%00.0%HealthcareIBIO INC$0$129,344 â–¼-100.0%00.0%COM NEWPRQRProQR Therapeutics$0$110,947 â–¼-100.0%00.0%HealthcareABSIAbsci$0$63,735 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
